Anti-alpha V immunoliposome compositions, methods and uses
AssigneeCentocor Ortho Biotech Inc.
InventorsJoshua Goldstein, Allen Magill, Deepak Saini, Linda A. Snyder, Raymond Sweet, Steve P. Weng
Life of this patent
Estimating the term…
Loading patent…
AssigneeCentocor Ortho Biotech Inc.
InventorsJoshua Goldstein, Allen Magill, Deepak Saini, Linda A. Snyder, Raymond Sweet, Steve P. Weng
Estimating the term…
An immunoliposome composition targeted to the alphaV-integrin subunit of integrin receptors comprised of ligand-targeted liposomes bearing at least one targeting-ligand derived from an antibody and having binding specificity for at least one integrin receptor comprising an alpha V subunit including αvβ1, αvβ3 αvβ5, αvβ6, or αvβ8 integrin cell receptors is described. The antibody-derived targeting ligand may be a Fab′ fragment, a scFv, or the like. Binding of the immunoliposome to αv-integrin expressing cells, preferably results in internalization of the immunoliposome for cytoplasmic delivery of a liposome-entrapped agent.
An antibody derived targeting-ligand capable of monovalent binding and having specificity for alpha V integrin comprising:
Dependencies are inferred from the claim text.